Cross-Phenotype GWAS Supports Shared Genetic Susceptibility to Systemic Sclerosis and Primary Biliary Cholangitis

Yiming Luo,Atlas Khan,Lili Liu,Cue Hyunkyu Lee,Gabriel J. Perreault,Sydney F. Pomenti,Pravitt Gourh,Krzysztof Kiryluk,Elana J. Bernstein
DOI: https://doi.org/10.1101/2024.07.01.24309721
2024-07-03
Abstract:Objective An increased risk of primary biliary cholangitis (PBC) has been reported in patients with systemic sclerosis (SSc). Our study aims to investigate the shared genetic susceptibility between the two disorders and to define candidate causal genes using cross-phenotype GWAS meta-analysis. Methods We performed cross-phenotype GWAS meta-analysis and colocalization analysis for SSc and PBC. We performed both genome-wide and locus-based analysis, including tissue and pathway enrichment analyses, fine-mapping, colocalization analyses with expression quantitative trait loci (eQTL) and protein quantitative trait loci (pQTL) datasets, and phenome-wide association studies (PheWAS). Finally, we used an integrative approach to prioritize candidate causal genes from the novel loci. Results We detected a strong genetic correlation between SSc and PBC (rg = 0.84, p = 1.7 x 10-6). In the cross-phenotype GWAS meta-analysis, we identified 44 non-HLA loci that reached genome-wide significance (p < 5 x 10-8). Evidence of shared causal variants between SSc and PBC was found for nine loci, five of which were novel. Integrating multiple sources of evidence, we prioritized CD40, ERAP1, PLD4, SPPL3, and CCDC113 as novel candidate causal genes. The CD40 risk locus colocalized with trans-pQTLs of multiple plasma proteins involved in B cell function. Conclusion Our study supports a strong shared genetic susceptibility between SSc and PBC. Through cross-phenotype analyses, we have prioritized several novel candidate causal genes and pathways for these disorders.
Rheumatology
What problem does this paper attempt to address?
### Problems the paper attempts to solve This paper aims to explore the shared genetic susceptibility between systemic sclerosis (SSc) and primary biliary cholangitis (PBC), and identify candidate pathogenic genes through cross - phenotype genome - wide association study (Cross - Phenotype GWAS). ### Background information - **Systemic sclerosis (SSc)**: A multi - system autoimmune disease, characterized by fibrosis, vasculopathy and inflammation. - **Primary biliary cholangitis (PBC)**: An autoimmune liver disease, characterized by inflammation of the intrahepatic bile ducts leading to liver fibrosis. - **Epidemiological data**: The prevalence of PBC in SSc patients is significantly higher than that in the general population (2 - 2.5% vs 0.4%), suggesting that there may be a common pathogenesis between these two diseases. - **Known genetic susceptibility**: Previous genome - wide association studies (GWAS) have identified multiple genomic loci associated with SSc and PBC. ### Research objectives 1. **Evaluate genetic correlation**: Estimate the global genetic correlation between SSc and PBC through linkage disequilibrium score regression (LDSR). 2. **Identify shared genetic loci**: Identify pleiotropic loci shared in SSc and PBC through cross - phenotype GWAS meta - analysis. 3. **Prioritize candidate pathogenic genes**: Combine multiple data sets and analysis methods to prioritize possible pathogenic genes. ### Main findings - **Strong genetic correlation**: There is a strong genetic correlation between SSc and PBC ($r_g = 0.84$, $p = 1.7\times10^{-6}$), and its strength is comparable to the genetic correlation between SSc and systemic lupus erythematosus (SLE). - **Shared genetic loci**: Through cross - phenotype GWAS meta - analysis, 44 non - HLA loci reaching genome - wide significance ($p < 5\times10^{-8}$) were identified, among which 9 loci had shared causal variants and 5 were newly discovered loci. - **Candidate pathogenic genes**: By integrating multiple evidence, 5 new candidate pathogenic genes were prioritized: CD40, ERAP1, PLD4, SPPL3 and CCDC113. - **CD40 risk allele**: The CD40 risk allele is associated with lower CD40 levels, but through causal inference analysis, it was found that this decreased CD40 level leads to an increase in the levels of multiple plasma proteins related to B - cell function, including CD40 ligand. ### Conclusion This study supports the existence of a strong shared genetic susceptibility between SSc and PBC. Through cross - phenotype analysis, the researchers identified and prioritized several new candidate pathogenic genes and pathways, providing important clues for further mechanistic studies.